Company / Capital Expenditures
Edesa Biotech, Inc. Capital Expenditures History
FY2014-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$4.9K
FY2021
5-year range
$4.9K / $302.7K
FY2017-FY2021
Trend
-40.0%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 7 years, ranging from $4,856 in FY2021 to $302,733 in FY2018.
Based on SEC 10-K filings.
$4,856 in FY2021 with a 5-year CAGR of -55.5%.
Declined from $302,733 to $4,856 over the past 3 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -74.8%
- 5-Year CAGR
- -55.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -55.5%, indicating a declining trend.
- In FY2021, capital expenditures decreased 40.0% year-over-year.
- Peak capital expenditures was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $4.9K | -40.0% |
| FY2020 | $8.1K | -97.3% |
| FY2018 | $302.7K | +10.2% |
| FY2017 | $274.6K | -1.6% |
| FY2016 | $279.1K | +2824.9% |
| FY2015 | $9.5K | -87.8% |
| FY2014 | $78.3K | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026